Sorry, you need to enable JavaScript to visit this website.
  1. Home
  2. Our Science
  3. Clinical Trials
  4. Plain Language Study Results Summaries

Plain Language Study Results Summaries

What Are Plain Language Study Results Summaries?

Plain Language Study Results Summaries are descriptions in everyday language of the design and results of clinical studies. These summaries, also called plain language summaries, simple summaries, and trial results summaries, are intended to make clinical results understandable and accessible to patients, healthcare providers, caregivers, researchers, and a general audience.

Please use the search function below to find Plain Language Study Results Summaries for Pfizer-sponsored global clinical trials.

Filter Results

Refine your search results by using the dropdown filters below. Click “reset” to return to the full list of available studies.

A Study of MEK162 vs. Physician’s Choice Chemotherapy in Patients With Low-Grade Serous Ovarian, Fallopian Tube, or Peritoneal Cancer
Category & Conditions: Cancer
Study Phase : 3
Medicine: MEKTOVI® TABLETS(BINIMETINIB)
Language: English
ViewDownloadPrint
Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS Mutation
Category & Conditions: Cancer
Study Phase : 1/2
Medicine: MEKTOVI® TABLETS(BINIMETINIB), OPDIVO®(NIVOLUMAB), YERVOY®(IPILIMUMAB)
Language: English
ViewDownloadPrint
A Study to Compare the Amount of Prazosin Hydrochloride in Participants’ Blood After Taking Capsules Manufactured at Different Sites.
Category & Conditions: Cardiovasular Diseases and Conditions
Study Phase : 1
Medicine: MINIPRESS®(PRAZOSIN HYDROCHLORIDE)
Language: English
ViewDownloadPrint
A study to assess the general safety and effect of gemtuzumab ozogamicin (MYLOTARG™) on the heart of patients with CD33-positive acute myeloid leukemia and to see how the drug moves through the body
Category & Conditions: Cancer
Study Phase : 4
Medicine: MYLOTARG™(GEMTUZUMAB OZOGAMICIN FOR INJECTION)
Language: English
ViewDownloadPrint
Pharmacokinetic Study in Healthy Participants to Compare Study Drug (pegfilgrastim-apgf) Given by Two Methods: On-body Injector or Prefilled Syringe (Needle)
Category & Conditions: Cancer
Study Phase : 1
Medicine: NYVEPRIA™(PEGFILGRASTIM-APGF)
Language: English
ViewDownloadPrint
Safety and Efficacy of Dexmedetomidine (DEX) for Sedation in Children Aged Between 1 Month and Up to 17 Years Undergoing an MRI Scan
Category & Conditions: Neurological Diseases and Conditions
Study Phase : 3/4
Medicine: PRECEDEX™(DEXMEDETOMIDINE HYDROCHLORIDE)
Language: English
ViewDownloadPrint
Testing the safety and effectiveness of a vaccine that protects people from a certain kind of infection (pneumococcal disease) after adding a preservative to the vaccine
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PREVNAR 13(PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE [DIPHTHERIA CRM197 PROTEIN])
Language: English
ViewDownloadPrint
A Study Investigating a Single Dose of 13-Valent Pneumococcal Conjugate Vaccine in Japanese Participants Aged 6 to 64 Years With Illnesses That Mean They Are More Likely to Get Pneumococcal Disease
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PREVNAR 13(PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE [DIPHTHERIA CRM197 PROTEIN])
Language: English
ViewDownloadPrint
A Study of 13vPnC Safety in Healthy Adults 18 to 49 Years Old in India
Category & Conditions: Vaccine-related Conditions
Study Phase : 4
Medicine: PREVNAR 13(PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE [DIPHTHERIA CRM197 PROTEIN])
Language: English
ViewDownloadPrint
A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis
Category & Conditions: Cardiovasular Diseases and Conditions
Study Phase : 3
Medicine: RETACRIT INJECTION(EPOETIN ALFA-EPBX)
Language: English
ViewDownloadPrint
A Randomized Trial of Sildenafil in Babies with Breathing Problems
Category & Conditions: Cardiovasular Diseases and Conditions
Study Phase : 3
Medicine: REVATIO®(SILDENAFIL)
Language: English
ViewDownloadPrint
A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)
Category & Conditions: Cancer
Study Phase : 3
Medicine: RUXIENCE™(RITUXIMAB-PVVR)
Language: English
ViewDownloadPrint